Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Ma
SCOPE HEALTH
Lack of Assurance of Sterility
1 recall found for SCOPE HEALTH — April 2026.
The recalls listed below are active notices associated with SCOPE HEALTH in the FDA, NHTSA, USDA, and CPSC databases. None of the current recalls are classified as urgent. The current recall involves sterility concerns. Check the specific lot numbers, model numbers, or production date codes in each notice carefully — a recall typically covers specific production runs, not everything a manufacturer sells.
A manufacturer appearing in the recall database does not indicate an ongoing safety failure. High-volume companies with large product lines naturally appear more frequently. What matters is whether your specific product — identified by lot number, model number, or date code — is included in a recall notice.
Browse all medication recalls →SCOPE HEALTH
Lack of Assurance of Sterility